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We describe clonal shifts in  vanA Enterococcus fae-
cium  isolates from clinical samples obtained from 
patients in Denmark from 2015 to the first quarter (Q1) 
of 2019. During Q1 2019, the vancomycin-variable ente-
rococci (VVE) ST1421-CT1134  vanA E. faecium  became 
the most dominant  vanA E. faecium  clone and has 
spread to all five regions in Denmark. Among 174  E. 
faecium  isolates with vanA, vanB or vanA/vanB genes 
in Q1 2019, 44% belonged to this type.
We describe the clonal shift for vanA Enterococcus fae-
cium during the last 4 years and the national spread of 
a vancomycin-variable  vanA E. faecium  ST1421-CT1134 
clone in Denmark. The aim is to highlight the impor-
tance of using molecular methods for detecting van-
comycin-variable enterococci (VVE), and to alert other 
countries about this emerging nosocomial clone.
Vancomycin-variable enterococci
Vancomycin-variable enterococci (VVE) are  E. fae-
cium  harboring the  vanA  gene complex, but being 
phenotypically vancomycin susceptible [1,2]. VVE can 
only be detected by molecular methods and cannot be 
cultured on selective vancomycin-containing media. 
Different clones of VVE have caused nosocomial out-
breaks and development of vancomycin-resistant rever-
tant mutants  in vitro  and  in vivo  has been described 
[1,3-5]. This makes the detection of VVE highly impor-
tant in clinical samples in order to assure relevant 
antibiotic treatment and in screening samples to avoid 
nosocomial spread. In 2015 and 2016, sporadic VVE 
with different genetic background were detected in 
the Capital Region of Denmark, in connection with 
vancomycin-resistant enterococci (VRE) outbreaks 
(data not shown). In 2016, a VVE clone belonging to 
ST1421-CT1134, which displays variable vancomycin 
susceptibility (minimum inhibitory concentration (MIC) 
1 to ≥ 256 mg/ml) was detected in screening samples 
from a hospital in the Capital Region [5]. One strain, 
Efm-V1511, belonging to this clone was characterised 
by Hansen et al. [5]. Efm-V1511 had a 49.6 Kp plasmid, 
which carried the Tn1546 (vanA transposon). Tn1546 was 
truncated in  vanX  by a 252 bp 3’ deletion explain-
ing the vancomycin susceptibility of Efm-V1511. In 
ST1421-CT1134 isolates resistant to vancomycin, resist-
ance could be attributed to changes in  ddl  disrupting 
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gene function sometimes accompanied by changes 
in  vanS, increased pHVH-V1511 copy number or the 
existence of an additional  vanA-containing plasmid 
encoding a functional vanX [5].
National surveillance of vancomycin-
resistant and vancomycin-variable 
enterococci
We have previously described the surveillance of 
vancomycin-resistant enterococci (VRE) in clinical iso-
lates in Denmark from 2005 to 2015 [6]. In the present 
study, we follow up and describe the data from isolates 
obtained from 2016 through the first quarter (Q1) of 
2019. Since 2005, VRE isolates from clinical samples, 
e.g. urine, blood and tissue, as opposed to screening 
(faecal) isolates have been voluntarily submitted to 
Statens Serum Institut (SSI) from Danish Departments 
of Clinical Microbiology (DCM) for species identifica-
tion, genotyping and surveillance (Figure 1) [7]. Only 
one isolate per patient per 12 months was included. 
All VRE isolates (699  E. faecium  and 30  E. faecalis) 
were tested for the presence of vancomycin resistance 
genes vanA and vanB by PCR from 2005 through 2014.
From 2015 through Q1 2019, all clinical VRE/VVE iso-
lates (n = 1,935) underwent whole-genome sequencing 
(WGS) as previously described [6]. From the WGS data, 
multilocus sequence type (MLST), and van genes were 
extracted  in silico. The isolates were further subtyped 
in SeqSphere + (Ridom GmbH, Münster, Germany 
(http://www.ridom.de/seqsphere/)) using the cgMLST 
scheme by de Been et al. [8] for E. faecium.
VVE diagnostic algorithms have differed substantially 
over time and between the five Danish regions. In 2017, 
testing of phenotypically vancomycin-susceptible  E. 
faecium  isolates from blood cultures for the presence 
of vanA/vanBgenes by PCR was introduced in the DCMs 
in the Capital Region. During 2018, this was expanded 
to testing of all clinical E. faecium isolates. During 2018, 
molecular testing by PCR of E. faecium from all clinical 
samples was also implemented in one of the four DCMs 
in the Region of Southern Denmark. Furthermore,  E. 
faecium  isolates from blood cultures were tested by 
PCR for vanA/vanB genes in another DCM in the Region 
of Southern Denmark and in the DCM in the Central 
Denmark Region in 2018. In Q1 2019, diagnostic 
algorithms to detect VVE have expanded. Most of the 
DCMs across Denmark test at least all blood culture E. 
faecium  isolates for the presence of vanA genes using 
PCR.
Enterococcus faecium and Enterococcus 
faecalis isolates from clinical samples 
carrying vanA and vanB genes
From 2005 to Q1 2019, 2,503 vanA E. faecium, 74 vanB 
E. faecium, 32 vanA/vanB E. faecium, 12 vanA E. faeca-
lis, and 43 vanB E. faecalis  from clinical samples were 
submitted to SSI (Figure 2).
Emergence and disappearance of 
major Enterococcus faecium clones
Of the 1,935 VRE/VVE isolates obtained from 2015 
through Q1 2019, 1,910 were E. faecium and 25 E. fae-
calis (Figure 2).
The E. faecium isolates belonged to 29 sequence types 
(STs). ST80 (22%), ST203 (65%) and ST1421 (9%) were 
most prevalent. Typing by cgMLST revealed 156 differ-
ent complex types (CTs).
The 13 most common types of  vanA,  vanB  and  vanA/
vanB  E. faecium  from 2015 to Q1 2019 are shown 
in  Table 1. From 2015 to 2019, three types were domi-
nating: ST80-CT14 vanA E. faecium, ST203-CT859 vanA 
E. faecium and ST1421-CT1134 vanA E. faecium (Table 1).
In 2015, 22% of the  E. faecium  isolates belonged to 
ST80-CT14 vanA E. faecium. The type decreased during 
2016.
ST203-CT859  vanA E. faecium  isolates were first 
detected during the end of 2014 [6]. It emerged very 
fast and was the most prevalent vanA E. faecium  type 
(together with its subtypes CT1051 and CT1507) during 
2015 to 2017, but decreased in 2018 (Table1). In Q1 2019 
only 12% of the VRE/VVE E. faecium  isolates belonged 
to ST203-CT859.
In 2017, 3% of the E. faecium  isolates belonged to the 
VVE clone, ST1421-CT1134  vanA E. faecium.  This type 
Figure 1
The five healthcare regions and the 10 Departments of 
Clinical Microbiology, Denmark, 2019
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Modified from DANMAP 2017 [7].
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was only detected from clinical samples from the 
Capital Region. In 2018, 34% of the E. faecium isolates 
belonged to ST1421-CT1134 and were detected in the 
Capital Region, the Region Zealand and from one DCM 
in the Region of Southern Denmark (Table 1,  Table 2). 
During Q1 2019, ST1421-CT1134 vanA E. faecium was the 
most prevalent type (44%) (Table 1). It was detected 
in all five regions of Denmark, 50 isolates from the 
Capital Region, one isolate from Region Zealand, 23 
isolates from the Region of Southern Denmark, two 
isolates from Central Denmark Region and one isolate 
from the North Denmark Region (Table 2). Furthermore, 
ST1421-CT1134  vanA E. faecium  spread to the Faroe 
Islands during 2018 and 2019 (data not shown).
Discussion and conclusion
During 2005 to Q1 2019, most of the Danish clinical 
VRE isolates have been  vanA E. faecium  isolates. This 
study shows that predominating clones shifted over 
time and, importantly, the emergence of a vancomycin-
variable clone, ST1421-CT1134 vanA E. faecium, that has 
spread to all the five Danish regions in 2019.
Although the E. faecium isolates belonged to 156 CTs, three 
types (ST80-CT14  vanA E. faecium,  ST203-CT859  vanA 
E. faecium, ST1421-CT1134 vanA E. faecium) have domi-
nated during the last 4 years.
ST80-CT14 vanA E. faecium was highly prevalent in the 
Capital Region during 2012 to 2015 [9]. The vanA E. fae-
ciumconstituting Group2_ST80 in the paper by Pinholt 
et al. [9] belonged to ST80-CT14 (data not shown). On 
a national level, the numbers of ST80-CT14 vanA E. fae-
cium  decreased during 2016 to 2018, and this clone 
was not detected during Q1 2019.
ST203-CT859  vanA E. faecium  emerged during 2015 
through 2017 and nearly disappeared 2019. This clone 
has spread to Sweden, the Faroe Islands and Greenland 
[6,7].
Because of differences in diagnostic algorithms, 
there is a detection bias of VVE. It seems very likely 
that ST1421-CT1134  vanA E. faecium  have been under-
reported in some regions at least during some periods. 
Thus, the rising incidence could partly be explained by 
Figure 2
Vancomycin-resistant and vancomycin-variable Enterococcus faecium and vancomycin-resistant E. faecalis isolates from 
clinical samples carrying van genes, Denmark, 2005–Q1 2019 (n = 2,664)
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increasing molecular testing of vancomycin susceptible 
isolates. However, a sharply increasing incidence has 
also been seen in DCM with extensive testing for VVE.
The origin of ST80-CT14  vanA E. faecium  and 
ST203-CT859  vanA E. faecium  are still unknown.  vanA 
E. faeciumisolates belonging to ST1421-CT1134 have 
also been reported from Australia, but these isolates 
have not been VVE [10]. Why these three clones were 
so successful is unknown.
The spread of the VVE clone, ST1421-CT1134  vanA E. 
faecium, in Denmark is of concern, especially since VVE 
diagnostic is challenging. Because of this, the clone is 
likely to be underdiagnosed, which facilitates further 
spread. Since cross-border spread has been described 
for VRE, countries with patients transferred from 
Denmark should be aware of the vancomycin-variable 
ST1421-CT1134 vanA E. faecium clone.
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Table 1
Description of the most common types of vanA and/or vanB Enterococcus faecium by MLST and cgMLST, Denmark, 2015–
Q1 2019 (n = 1,910)
Types
2015 
 
(n = 369)
2016 
 
(n = 427)
2017 
 
(n = 425)
2018 
 
(n = 515)
Q1 2019 
 
(n = 174)
n % n % n % n % n %
ST80-CT14 vanA 81 22 38 9 15 4 1  < 1 ND ND
ST80-CT24 vanA 23 6 19 4 11 3 2 < 1 4 2
ST80-CT860 vanA 7 2 11 3 ND ND ND ND ND ND
ST80-CT866 vanA 14 4 10 2 7 2 ND ND ND ND
ST80-CT991 vanA ND ND 11 3 9 2 6 1 ND ND
ST80-CT1160 vanA ND ND ND ND 7 2 10 2 ND ND
ST80-CT1064 vanA/vanB ND ND 2 < 1 8 2 23 5 4 2
ST80-CT1729 vanA ND ND ND ND ND ND 22 4 2 1
ST117-CT873 vanA 5 1 12 3 ND ND ND ND ND ND
ST117-CT1180 vanA ND ND ND ND 9 2 30 6 7 4
ST117-CT36 vanB ND ND ND ND ND ND 2 < 1 16 9
ST203-CT859 (subtypes CT1051 and CT1507) vanA 188 51 271 64 265 63 161 31 20 12
ST1421-CT1134 vanA ND ND 2 < 1 13 3 176 34 77 44
Other types 51 14 51 12 81 19 82 16 44 25
CT: cluster type (cgMLST); MLST: multilocus sequence typing; ND: not detected; ST: sequence type (MLST); Q1: first quarter.
Table 2
Regional occurrence of ST1421-CT1134 vanA E. faecium, Denmark, 2016–Q1 2019 (n = 268)
Region
2016 
 
(n = 2)
2017 
 
(n = 13)
2018 
 
(n = 176)
Q1 2019 
 
(n = 77)
Capital Region of Denmark 2 9 158 50
Region Zealand ND 3 9 1
Region of Southern Denmark ND ND 9 23
Central Denmark Region ND ND ND 2
North Denmark Region ND 1 ND 1
Q1: first quarter.
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